nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabrafenib—NEK11—lymph node—gallbladder cancer	0.00663	0.124	CbGeAlD
Dabrafenib—SIK1—pancreas—gallbladder cancer	0.00503	0.0943	CbGeAlD
Dabrafenib—LIMK1—lymph node—gallbladder cancer	0.00475	0.089	CbGeAlD
Dabrafenib—RAF1—epithelium—gallbladder cancer	0.0045	0.0843	CbGeAlD
Dabrafenib—RAF1—pancreas—gallbladder cancer	0.00401	0.0751	CbGeAlD
Dabrafenib—BRAF—liver—gallbladder cancer	0.00383	0.0717	CbGeAlD
Dabrafenib—SLCO1B3—liver—gallbladder cancer	0.0033	0.0618	CbGeAlD
Dabrafenib—SIK1—liver—gallbladder cancer	0.0032	0.06	CbGeAlD
Dabrafenib—BRAF—lymph node—gallbladder cancer	0.00293	0.055	CbGeAlD
Dabrafenib—RAF1—liver—gallbladder cancer	0.00255	0.0478	CbGeAlD
Dabrafenib—SIK1—lymph node—gallbladder cancer	0.00246	0.046	CbGeAlD
Dabrafenib—RAF1—lymph node—gallbladder cancer	0.00195	0.0366	CbGeAlD
Dabrafenib—SLCO1B1—liver—gallbladder cancer	0.00191	0.0357	CbGeAlD
Dabrafenib—CYP2C8—liver—gallbladder cancer	0.00108	0.0203	CbGeAlD
Dabrafenib—ABCG2—liver—gallbladder cancer	0.00105	0.0198	CbGeAlD
Dabrafenib—RAF1—Signaling by ERBB2—ERBB2—gallbladder cancer	0.000944	0.000997	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by Insulin receptor—NRAS—gallbladder cancer	0.000943	0.000996	CbGpPWpGaD
Dabrafenib—RAF1—DAP12 signaling—ERBB2—gallbladder cancer	0.00094	0.000993	CbGpPWpGaD
Dabrafenib—BRAF—PDGFR-beta signaling pathway—HRAS—gallbladder cancer	0.000939	0.000992	CbGpPWpGaD
Dabrafenib—RAF1—ErbB1 downstream signaling—EGFR—gallbladder cancer	0.00093	0.000983	CbGpPWpGaD
Dabrafenib—RAF1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—HRAS—gallbladder cancer	0.000929	0.000981	CbGpPWpGaD
Dabrafenib—BRAF—MAPK Signaling Pathway—EGFR—gallbladder cancer	0.000923	0.000975	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—ERBB3—gallbladder cancer	0.000922	0.000974	CbGpPWpGaD
Dabrafenib—ABCB1—epithelium—gallbladder cancer	0.000917	0.0172	CbGeAlD
Dabrafenib—RAF1—Signaling Pathways in Glioblastoma—HRAS—gallbladder cancer	0.000911	0.000962	CbGpPWpGaD
Dabrafenib—RAF1—Retinoblastoma (RB) in Cancer—TP53—gallbladder cancer	0.000908	0.000959	CbGpPWpGaD
Dabrafenib—BRAF—Signaling by FGFR—KRAS—gallbladder cancer	0.000898	0.000949	CbGpPWpGaD
Dabrafenib—BRAF—EGF/EGFR Signaling Pathway—KRAS—gallbladder cancer	0.000898	0.000949	CbGpPWpGaD
Dabrafenib—RAF1—PDGFR-beta signaling pathway—NRAS—gallbladder cancer	0.000888	0.000938	CbGpPWpGaD
Dabrafenib—BRAF—Signaling by FGFR in disease—EGFR—gallbladder cancer	0.000886	0.000936	CbGpPWpGaD
Dabrafenib—RAF1—IRS-mediated signalling—HRAS—gallbladder cancer	0.000885	0.000935	CbGpPWpGaD
Dabrafenib—RAF1—Fc epsilon receptor (FCERI) signaling—ERBB2—gallbladder cancer	0.000884	0.000934	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by FGFR in disease—ERBB2—gallbladder cancer	0.000884	0.000934	CbGpPWpGaD
Dabrafenib—RAF1—DAP12 interactions—ERBB2—gallbladder cancer	0.000884	0.000934	CbGpPWpGaD
Dabrafenib—RAF1—ErbB1 downstream signaling—KRAS—gallbladder cancer	0.000879	0.000929	CbGpPWpGaD
Dabrafenib—LIMK1—Axon guidance—HRAS—gallbladder cancer	0.000877	0.000926	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by EGFR—ERBB2—gallbladder cancer	0.000876	0.000925	CbGpPWpGaD
Dabrafenib—BRAF—MAPK Signaling Pathway—KRAS—gallbladder cancer	0.000872	0.000921	CbGpPWpGaD
Dabrafenib—BRAF—Signaling by NGF—ERBB2—gallbladder cancer	0.00087	0.000919	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by EGFR in Cancer—ERBB2—gallbladder cancer	0.000868	0.000917	CbGpPWpGaD
Dabrafenib—RAF1—VEGFA-VEGFR2 Pathway—KRAS—gallbladder cancer	0.000866	0.000915	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by PDGF—ERBB2—gallbladder cancer	0.000864	0.000913	CbGpPWpGaD
Dabrafenib—BRAF—NGF signalling via TRKA from the plasma membrane—NRAS—gallbladder cancer	0.000861	0.000909	CbGpPWpGaD
Dabrafenib—RAF1—IRS-related events—HRAS—gallbladder cancer	0.000861	0.000909	CbGpPWpGaD
Dabrafenib—RAF1—Focal Adhesion—BCL2—gallbladder cancer	0.00086	0.000908	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by Interleukins—KRAS—gallbladder cancer	0.000859	0.000908	CbGpPWpGaD
Dabrafenib—BRAF—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—gallbladder cancer	0.000858	0.000906	CbGpPWpGaD
Dabrafenib—RAF1—Integrated Pancreatic Cancer Pathway—BCL2—gallbladder cancer	0.000856	0.000904	CbGpPWpGaD
Dabrafenib—LIMK1—Developmental Biology—NRAS—gallbladder cancer	0.000855	0.000904	CbGpPWpGaD
Dabrafenib—RAF1—IRS-related events triggered by IGF1R—HRAS—gallbladder cancer	0.000853	0.000901	CbGpPWpGaD
Dabrafenib—RAF1—TCR Signaling Pathway—HRAS—gallbladder cancer	0.000845	0.000893	CbGpPWpGaD
Dabrafenib—BRAF—Integrated Breast Cancer Pathway—TP53—gallbladder cancer	0.000844	0.000892	CbGpPWpGaD
Dabrafenib—BRAF—Focal Adhesion—EGFR—gallbladder cancer	0.000837	0.000884	CbGpPWpGaD
Dabrafenib—BRAF—Signaling by FGFR in disease—KRAS—gallbladder cancer	0.000837	0.000884	CbGpPWpGaD
Dabrafenib—RAF1—Focal Adhesion—ERBB2—gallbladder cancer	0.000835	0.000882	CbGpPWpGaD
Dabrafenib—RAF1—Integrated Pancreatic Cancer Pathway—ERBB2—gallbladder cancer	0.000832	0.000879	CbGpPWpGaD
Dabrafenib—RAF1—Insulin receptor signalling cascade—HRAS—gallbladder cancer	0.00083	0.000877	CbGpPWpGaD
Dabrafenib—RAF1—IGF1R signaling cascade—HRAS—gallbladder cancer	0.00083	0.000877	CbGpPWpGaD
Dabrafenib—RAF1—TNF alpha Signaling Pathway—HRAS—gallbladder cancer	0.00083	0.000877	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by VEGF—KRAS—gallbladder cancer	0.000817	0.000863	CbGpPWpGaD
Dabrafenib—ABCB1—pancreas—gallbladder cancer	0.000817	0.0153	CbGeAlD
Dabrafenib—RAF1—Signaling by Insulin receptor—KRAS—gallbladder cancer	0.000812	0.000857	CbGpPWpGaD
Dabrafenib—ABCG2—lymph node—gallbladder cancer	0.000809	0.0151	CbGeAlD
Dabrafenib—RAF1—Signaling by SCF-KIT—NRAS—gallbladder cancer	0.000807	0.000852	CbGpPWpGaD
Dabrafenib—RAF1—B Cell Receptor Signaling Pathway—HRAS—gallbladder cancer	0.000796	0.000841	CbGpPWpGaD
Dabrafenib—BRAF—NGF signalling via TRKA from the plasma membrane—EGFR—gallbladder cancer	0.000784	0.000829	CbGpPWpGaD
Dabrafenib—RAF1—NGF signalling via TRKA from the plasma membrane—ERBB2—gallbladder cancer	0.000783	0.000827	CbGpPWpGaD
Dabrafenib—RAF1—Senescence and Autophagy in Cancer—TP53—gallbladder cancer	0.000781	0.000825	CbGpPWpGaD
Dabrafenib—LIMK1—Developmental Biology—EGFR—gallbladder cancer	0.000779	0.000823	CbGpPWpGaD
Dabrafenib—RAF1—Integrin-mediated Cell Adhesion—HRAS—gallbladder cancer	0.000777	0.000821	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—KEAP1—gallbladder cancer	0.000777	0.000821	CbGpPWpGaD
Dabrafenib—BRAF—MAPK Signaling Pathway—TP53—gallbladder cancer	0.000775	0.000819	CbGpPWpGaD
Dabrafenib—RAF1—Regulation of Actin Cytoskeleton—NRAS—gallbladder cancer	0.000772	0.000815	CbGpPWpGaD
Dabrafenib—RAF1—Downstream signaling of activated FGFR—NRAS—gallbladder cancer	0.000772	0.000815	CbGpPWpGaD
Dabrafenib—RAF1—PDGFR-beta signaling pathway—KRAS—gallbladder cancer	0.000765	0.000808	CbGpPWpGaD
Dabrafenib—BRAF—EGF/EGFR Signaling Pathway—HRAS—gallbladder cancer	0.000763	0.000806	CbGpPWpGaD
Dabrafenib—BRAF—Signaling by FGFR—HRAS—gallbladder cancer	0.000763	0.000806	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by ERBB4—NRAS—gallbladder cancer	0.00076	0.000802	CbGpPWpGaD
Dabrafenib—LIMK1—Innate Immune System—NRAS—gallbladder cancer	0.000755	0.000798	CbGpPWpGaD
Dabrafenib—RAF1—Senescence and Autophagy in Cancer—HRAS—gallbladder cancer	0.000747	0.000789	CbGpPWpGaD
Dabrafenib—RAF1—ErbB1 downstream signaling—HRAS—gallbladder cancer	0.000747	0.000789	CbGpPWpGaD
Dabrafenib—BRAF—NGF signalling via TRKA from the plasma membrane—KRAS—gallbladder cancer	0.000741	0.000783	CbGpPWpGaD
Dabrafenib—LIMK1—Developmental Biology—KRAS—gallbladder cancer	0.000736	0.000778	CbGpPWpGaD
Dabrafenib—RAF1—VEGFA-VEGFR2 Pathway—HRAS—gallbladder cancer	0.000736	0.000777	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by SCF-KIT—EGFR—gallbladder cancer	0.000735	0.000776	CbGpPWpGaD
Dabrafenib—CYP3A4—liver—gallbladder cancer	0.000735	0.0138	CbGeAlD
Dabrafenib—RAF1—Signaling by Interleukins—HRAS—gallbladder cancer	0.00073	0.000772	CbGpPWpGaD
Dabrafenib—RAF1—Downstream signal transduction—NRAS—gallbladder cancer	0.000725	0.000766	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by FGFR—NRAS—gallbladder cancer	0.000722	0.000763	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by ERBB2—NRAS—gallbladder cancer	0.000718	0.000759	CbGpPWpGaD
Dabrafenib—RAF1—DAP12 signaling—NRAS—gallbladder cancer	0.000715	0.000755	CbGpPWpGaD
Dabrafenib—BRAF—Signaling by FGFR in disease—HRAS—gallbladder cancer	0.000711	0.000751	CbGpPWpGaD
Dabrafenib—RAF1—Regulation of Actin Cytoskeleton—EGFR—gallbladder cancer	0.000703	0.000743	CbGpPWpGaD
Dabrafenib—RAF1—Downstream signaling of activated FGFR—EGFR—gallbladder cancer	0.000703	0.000743	CbGpPWpGaD
Dabrafenib—RAF1—MAPK Signaling Pathway—NRAS—gallbladder cancer	0.000701	0.000741	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by VEGF—HRAS—gallbladder cancer	0.000695	0.000734	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by SCF-KIT—KRAS—gallbladder cancer	0.000694	0.000733	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by ERBB4—EGFR—gallbladder cancer	0.000692	0.000731	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by Insulin receptor—HRAS—gallbladder cancer	0.00069	0.000729	CbGpPWpGaD
Dabrafenib—LIMK1—Innate Immune System—EGFR—gallbladder cancer	0.000688	0.000727	CbGpPWpGaD
Dabrafenib—RAF1—DAP12 interactions—NRAS—gallbladder cancer	0.000673	0.00071	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by FGFR in disease—NRAS—gallbladder cancer	0.000673	0.00071	CbGpPWpGaD
Dabrafenib—RAF1—Fc epsilon receptor (FCERI) signaling—NRAS—gallbladder cancer	0.000673	0.00071	CbGpPWpGaD
Dabrafenib—BRAF—Focal Adhesion—HRAS—gallbladder cancer	0.000672	0.00071	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by EGFR—NRAS—gallbladder cancer	0.000667	0.000704	CbGpPWpGaD
Dabrafenib—RAF1—Regulation of Actin Cytoskeleton—KRAS—gallbladder cancer	0.000664	0.000702	CbGpPWpGaD
Dabrafenib—RAF1—Downstream signaling of activated FGFR—KRAS—gallbladder cancer	0.000664	0.000702	CbGpPWpGaD
Dabrafenib—BRAF—Signaling by NGF—NRAS—gallbladder cancer	0.000662	0.0007	CbGpPWpGaD
Dabrafenib—RAF1—Downstream signal transduction—EGFR—gallbladder cancer	0.000661	0.000698	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by EGFR in Cancer—NRAS—gallbladder cancer	0.000661	0.000698	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by FGFR—EGFR—gallbladder cancer	0.000658	0.000695	CbGpPWpGaD
Dabrafenib—RAF1—EGF/EGFR Signaling Pathway—EGFR—gallbladder cancer	0.000658	0.000695	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by PDGF—NRAS—gallbladder cancer	0.000658	0.000695	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by ERBB2—EGFR—gallbladder cancer	0.000654	0.000691	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by ERBB4—KRAS—gallbladder cancer	0.000654	0.000691	CbGpPWpGaD
Dabrafenib—RAF1—DAP12 signaling—EGFR—gallbladder cancer	0.000651	0.000688	CbGpPWpGaD
Dabrafenib—RAF1—TGF-beta Signaling Pathway—TP53—gallbladder cancer	0.000651	0.000687	CbGpPWpGaD
Dabrafenib—LIMK1—Innate Immune System—KRAS—gallbladder cancer	0.00065	0.000687	CbGpPWpGaD
Dabrafenib—RAF1—PDGFR-beta signaling pathway—HRAS—gallbladder cancer	0.00065	0.000686	CbGpPWpGaD
Dabrafenib—BRAF—Transmission across Chemical Synapses—HRAS—gallbladder cancer	0.000645	0.000681	CbGpPWpGaD
Dabrafenib—RAF1—MAPK Signaling Pathway—EGFR—gallbladder cancer	0.000639	0.000675	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—ERBB4—gallbladder cancer	0.000634	0.000669	CbGpPWpGaD
Dabrafenib—BRAF—NGF signalling via TRKA from the plasma membrane—HRAS—gallbladder cancer	0.00063	0.000665	CbGpPWpGaD
Dabrafenib—LIMK1—Developmental Biology—HRAS—gallbladder cancer	0.000626	0.000661	CbGpPWpGaD
Dabrafenib—RAF1—Downstream signal transduction—KRAS—gallbladder cancer	0.000624	0.00066	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by FGFR—KRAS—gallbladder cancer	0.000621	0.000656	CbGpPWpGaD
Dabrafenib—RAF1—EGF/EGFR Signaling Pathway—KRAS—gallbladder cancer	0.000621	0.000656	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by ERBB2—KRAS—gallbladder cancer	0.000618	0.000653	CbGpPWpGaD
Dabrafenib—RAF1—DAP12 signaling—KRAS—gallbladder cancer	0.000615	0.00065	CbGpPWpGaD
Dabrafenib—RAF1—Fc epsilon receptor (FCERI) signaling—EGFR—gallbladder cancer	0.000613	0.000647	CbGpPWpGaD
Dabrafenib—RAF1—DAP12 interactions—EGFR—gallbladder cancer	0.000613	0.000647	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by FGFR in disease—EGFR—gallbladder cancer	0.000613	0.000647	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—ERBB4—gallbladder cancer	0.000608	0.000643	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by EGFR—EGFR—gallbladder cancer	0.000607	0.000641	CbGpPWpGaD
Dabrafenib—RAF1—MAPK Signaling Pathway—KRAS—gallbladder cancer	0.000604	0.000638	CbGpPWpGaD
Dabrafenib—BRAF—Signaling by NGF—EGFR—gallbladder cancer	0.000603	0.000637	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by NGF—ERBB2—gallbladder cancer	0.000602	0.000636	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by EGFR in Cancer—EGFR—gallbladder cancer	0.000602	0.000636	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by PDGF—EGFR—gallbladder cancer	0.000599	0.000633	CbGpPWpGaD
Dabrafenib—RAF1—NGF signalling via TRKA from the plasma membrane—NRAS—gallbladder cancer	0.000596	0.000629	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—BCL2—gallbladder cancer	0.000595	0.000629	CbGpPWpGaD
Dabrafenib—RAF1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—gallbladder cancer	0.000594	0.000627	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by SCF-KIT—HRAS—gallbladder cancer	0.00059	0.000623	CbGpPWpGaD
Dabrafenib—RAF1—BDNF signaling pathway—HRAS—gallbladder cancer	0.00058	0.000613	CbGpPWpGaD
Dabrafenib—RAF1—Focal Adhesion—EGFR—gallbladder cancer	0.000579	0.000612	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by FGFR in disease—KRAS—gallbladder cancer	0.000579	0.000611	CbGpPWpGaD
Dabrafenib—RAF1—Fc epsilon receptor (FCERI) signaling—KRAS—gallbladder cancer	0.000579	0.000611	CbGpPWpGaD
Dabrafenib—RAF1—DAP12 interactions—KRAS—gallbladder cancer	0.000579	0.000611	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—ERBB2—gallbladder cancer	0.000578	0.000611	CbGpPWpGaD
Dabrafenib—RAF1—Integrated Pancreatic Cancer Pathway—EGFR—gallbladder cancer	0.000577	0.000609	CbGpPWpGaD
Dabrafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—gallbladder cancer	0.000576	0.000608	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by EGFR—KRAS—gallbladder cancer	0.000574	0.000606	CbGpPWpGaD
Dabrafenib—BRAF—Signaling by NGF—KRAS—gallbladder cancer	0.00057	0.000602	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by EGFR in Cancer—KRAS—gallbladder cancer	0.000569	0.000601	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by PDGF—KRAS—gallbladder cancer	0.000566	0.000598	CbGpPWpGaD
Dabrafenib—RAF1—Downstream signaling of activated FGFR—HRAS—gallbladder cancer	0.000565	0.000597	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by ERBB4—HRAS—gallbladder cancer	0.000556	0.000587	CbGpPWpGaD
Dabrafenib—LIMK1—Innate Immune System—HRAS—gallbladder cancer	0.000553	0.000584	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—ERBB3—gallbladder cancer	0.000548	0.000579	CbGpPWpGaD
Dabrafenib—RAF1—Axon guidance—ERBB2—gallbladder cancer	0.000545	0.000576	CbGpPWpGaD
Dabrafenib—RAF1—Integrated Pancreatic Cancer Pathway—KRAS—gallbladder cancer	0.000545	0.000575	CbGpPWpGaD
Dabrafenib—RAF1—NGF signalling via TRKA from the plasma membrane—EGFR—gallbladder cancer	0.000543	0.000573	CbGpPWpGaD
Dabrafenib—RAF1—MAPK Signaling Pathway—TP53—gallbladder cancer	0.000536	0.000567	CbGpPWpGaD
Dabrafenib—RAF1—Insulin Signaling—HRAS—gallbladder cancer	0.000533	0.000563	CbGpPWpGaD
Dabrafenib—RAF1—Downstream signal transduction—HRAS—gallbladder cancer	0.000531	0.000561	CbGpPWpGaD
Dabrafenib—RAF1—EGF/EGFR Signaling Pathway—HRAS—gallbladder cancer	0.000528	0.000558	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by FGFR—HRAS—gallbladder cancer	0.000528	0.000558	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—ERBB3—gallbladder cancer	0.000526	0.000556	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by ERBB2—HRAS—gallbladder cancer	0.000526	0.000555	CbGpPWpGaD
Dabrafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—gallbladder cancer	0.000524	0.000554	CbGpPWpGaD
Dabrafenib—RAF1—DAP12 signaling—HRAS—gallbladder cancer	0.000523	0.000552	CbGpPWpGaD
Dabrafenib—ABCB1—liver—gallbladder cancer	0.00052	0.00974	CbGeAlD
Dabrafenib—RAF1—NGF signalling via TRKA from the plasma membrane—KRAS—gallbladder cancer	0.000513	0.000542	CbGpPWpGaD
Dabrafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—gallbladder cancer	0.000495	0.000523	CbGpPWpGaD
Dabrafenib—BRAF—Neuronal System—HRAS—gallbladder cancer	0.000494	0.000522	CbGpPWpGaD
Dabrafenib—BRAF—Disease—ERBB4—gallbladder cancer	0.000492	0.00052	CbGpPWpGaD
Dabrafenib—RAF1—Fc epsilon receptor (FCERI) signaling—HRAS—gallbladder cancer	0.000492	0.00052	CbGpPWpGaD
Dabrafenib—RAF1—DAP12 interactions—HRAS—gallbladder cancer	0.000492	0.00052	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by FGFR in disease—HRAS—gallbladder cancer	0.000492	0.00052	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by EGFR—HRAS—gallbladder cancer	0.000488	0.000515	CbGpPWpGaD
Dabrafenib—BRAF—Signaling by NGF—HRAS—gallbladder cancer	0.000484	0.000512	CbGpPWpGaD
Dabrafenib—RAF1—Integrated Pancreatic Cancer Pathway—TP53—gallbladder cancer	0.000484	0.000511	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by EGFR in Cancer—HRAS—gallbladder cancer	0.000483	0.000511	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by PDGF—HRAS—gallbladder cancer	0.000481	0.000508	CbGpPWpGaD
Dabrafenib—RAF1—Cytokine Signaling in Immune system—NRAS—gallbladder cancer	0.000466	0.000492	CbGpPWpGaD
Dabrafenib—RAF1—Focal Adhesion—HRAS—gallbladder cancer	0.000465	0.000491	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by NGF—NRAS—gallbladder cancer	0.000458	0.000484	CbGpPWpGaD
Dabrafenib—RAF1—Transmission across Chemical Synapses—HRAS—gallbladder cancer	0.000446	0.000471	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—NRAS—gallbladder cancer	0.00044	0.000465	CbGpPWpGaD
Dabrafenib—RAF1—NGF signalling via TRKA from the plasma membrane—HRAS—gallbladder cancer	0.000436	0.00046	CbGpPWpGaD
Dabrafenib—BRAF—Disease—ERBB3—gallbladder cancer	0.000426	0.00045	CbGpPWpGaD
Dabrafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—gallbladder cancer	0.000421	0.000445	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by NGF—EGFR—gallbladder cancer	0.000417	0.000441	CbGpPWpGaD
Dabrafenib—RAF1—Axon guidance—NRAS—gallbladder cancer	0.000415	0.000438	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—gallbladder cancer	0.000404	0.000426	CbGpPWpGaD
Dabrafenib—RAF1—Cytokine Signaling in Immune system—KRAS—gallbladder cancer	0.000401	0.000424	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—EGFR—gallbladder cancer	0.000401	0.000423	CbGpPWpGaD
Dabrafenib—ABCB1—lymph node—gallbladder cancer	0.000399	0.00747	CbGeAlD
Dabrafenib—RAF1—Signaling by NGF—KRAS—gallbladder cancer	0.000394	0.000417	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—gallbladder cancer	0.000392	0.000414	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—ERBB2—gallbladder cancer	0.000389	0.000411	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—KRAS—gallbladder cancer	0.000379	0.0004	CbGpPWpGaD
Dabrafenib—RAF1—Axon guidance—EGFR—gallbladder cancer	0.000378	0.000399	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—ERBB4—gallbladder cancer	0.000369	0.00039	CbGpPWpGaD
Dabrafenib—RAF1—Axon guidance—KRAS—gallbladder cancer	0.000357	0.000377	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—BCL2—gallbladder cancer	0.000354	0.000373	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—ERBB4—gallbladder cancer	0.000345	0.000364	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—ERBB2—gallbladder cancer	0.000343	0.000363	CbGpPWpGaD
Dabrafenib—RAF1—Neuronal System—HRAS—gallbladder cancer	0.000342	0.000361	CbGpPWpGaD
Dabrafenib—RAF1—Cytokine Signaling in Immune system—HRAS—gallbladder cancer	0.000341	0.00036	CbGpPWpGaD
Dabrafenib—RAF1—Disease—ERBB4—gallbladder cancer	0.000341	0.00036	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by NGF—HRAS—gallbladder cancer	0.000335	0.000354	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—ERBB2—gallbladder cancer	0.00033	0.000348	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—HRAS—gallbladder cancer	0.000322	0.00034	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—ERBB3—gallbladder cancer	0.000319	0.000337	CbGpPWpGaD
Dabrafenib—RAF1—Axon guidance—HRAS—gallbladder cancer	0.000303	0.00032	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—ERBB3—gallbladder cancer	0.000298	0.000315	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—NRAS—gallbladder cancer	0.000296	0.000313	CbGpPWpGaD
Dabrafenib—RAF1—Disease—ERBB3—gallbladder cancer	0.000295	0.000311	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—NRAS—gallbladder cancer	0.00029	0.000307	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—gallbladder cancer	0.000272	0.000287	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—EGFR—gallbladder cancer	0.00027	0.000285	CbGpPWpGaD
Dabrafenib—BRAF—Disease—ERBB2—gallbladder cancer	0.000267	0.000282	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—NRAS—gallbladder cancer	0.000261	0.000276	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—gallbladder cancer	0.000257	0.000271	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—KRAS—gallbladder cancer	0.000255	0.000269	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—NRAS—gallbladder cancer	0.000251	0.000265	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—KRAS—gallbladder cancer	0.00025	0.000264	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—ERBB4—gallbladder cancer	0.000239	0.000252	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—EGFR—gallbladder cancer	0.000238	0.000251	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—EGFR—gallbladder cancer	0.000229	0.000241	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—gallbladder cancer	0.000228	0.000241	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—KRAS—gallbladder cancer	0.000225	0.000238	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—TP53—gallbladder cancer	0.000222	0.000235	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—HRAS—gallbladder cancer	0.000216	0.000229	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—KRAS—gallbladder cancer	0.000216	0.000228	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—HRAS—gallbladder cancer	0.000212	0.000224	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—ERBB3—gallbladder cancer	0.000206	0.000218	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—BCL2—gallbladder cancer	0.000206	0.000218	CbGpPWpGaD
Dabrafenib—BRAF—Disease—NRAS—gallbladder cancer	0.000203	0.000215	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—ERBB2—gallbladder cancer	0.0002	0.000211	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—HRAS—gallbladder cancer	0.000191	0.000202	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—ERBB2—gallbladder cancer	0.000187	0.000197	CbGpPWpGaD
Dabrafenib—BRAF—Disease—EGFR—gallbladder cancer	0.000185	0.000195	CbGpPWpGaD
Dabrafenib—RAF1—Disease—ERBB2—gallbladder cancer	0.000185	0.000195	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—HRAS—gallbladder cancer	0.000184	0.000194	CbGpPWpGaD
Dabrafenib—BRAF—Disease—KRAS—gallbladder cancer	0.000175	0.000185	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—NRAS—gallbladder cancer	0.000167	0.000176	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—NRAS—gallbladder cancer	0.000152	0.000161	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—EGFR—gallbladder cancer	0.000152	0.00016	CbGpPWpGaD
Dabrafenib—BRAF—Disease—HRAS—gallbladder cancer	0.000149	0.000157	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—KRAS—gallbladder cancer	0.000143	0.000151	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—NRAS—gallbladder cancer	0.000142	0.00015	CbGpPWpGaD
Dabrafenib—RAF1—Disease—NRAS—gallbladder cancer	0.000141	0.000148	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—EGFR—gallbladder cancer	0.000139	0.000146	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—KRAS—gallbladder cancer	0.000131	0.000138	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—EGFR—gallbladder cancer	0.00013	0.000137	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—ERBB2—gallbladder cancer	0.000129	0.000137	CbGpPWpGaD
Dabrafenib—RAF1—Disease—EGFR—gallbladder cancer	0.000128	0.000135	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—KRAS—gallbladder cancer	0.000122	0.000129	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—HRAS—gallbladder cancer	0.000122	0.000129	CbGpPWpGaD
Dabrafenib—RAF1—Disease—KRAS—gallbladder cancer	0.000121	0.000128	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—HRAS—gallbladder cancer	0.000111	0.000118	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—TP53—gallbladder cancer	0.000109	0.000115	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—HRAS—gallbladder cancer	0.000104	0.00011	CbGpPWpGaD
Dabrafenib—RAF1—Disease—HRAS—gallbladder cancer	0.000103	0.000109	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—NRAS—gallbladder cancer	9.84e-05	0.000104	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—EGFR—gallbladder cancer	8.96e-05	9.47e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—KRAS—gallbladder cancer	8.47e-05	8.95e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—TP53—gallbladder cancer	7.53e-05	7.95e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—HRAS—gallbladder cancer	7.2e-05	7.6e-05	CbGpPWpGaD
